These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 17319095)
1. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Asleh R; Levy AP Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095 [TBL] [Abstract][Full Text] [Related]
2. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Asleh R; Marsh S; Shilkrut M; Binah O; Guetta J; Lejbkowicz F; Enav B; Shehadeh N; Kanter Y; Lache O; Cohen O; Levy NS; Levy AP Circ Res; 2003 Jun; 92(11):1193-200. PubMed ID: 12750308 [TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia Induces Inflammatory Response of Human Macrophages to CD163-Mediated Scavenging of Hemoglobin-Haptoglobin Complexes. Matuschik L; Riabov V; Schmuttermaier C; Sevastyanova T; Weiss C; Klüter H; Kzhyshkowska J Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163309 [TBL] [Abstract][Full Text] [Related]
4. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis. Purushothaman M; Krishnan P; Purushothaman KR; Baber U; Tarricone A; Perez JS; Wiley J; Kini A; Sharma SK; Fuster V; Moreno PR Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2769-75. PubMed ID: 22982461 [TBL] [Abstract][Full Text] [Related]
5. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease. Goldenstein H; Levy NS; Levy AP Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143 [TBL] [Abstract][Full Text] [Related]
6. Hypothesis--haptoglobin genotype and diabetic nephropathy. Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716 [TBL] [Abstract][Full Text] [Related]
7. [HAPTOGLOBIN POLYMORPHISM AS AN INDEPENDENT PREDICTOR OF DIABETIC NEPHROPATHY AND RETINOPATHY]. Dahan I; Thauho N; Nakhoul F; Nakhoul N; Jabaly H; Farber E Harefuah; 2016 Jul; 155(7):439-442. PubMed ID: 28514126 [TBL] [Abstract][Full Text] [Related]
8. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus. Dalan R; Liuh Ling G Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294 [TBL] [Abstract][Full Text] [Related]
9. Trapping of human hemoglobin by haptoglobin: molecular mechanisms and clinical applications. Ratanasopa K; Chakane S; Ilyas M; Nantasenamat C; Bulow L Antioxid Redox Signal; 2013 Jun; 18(17):2364-74. PubMed ID: 22900934 [TBL] [Abstract][Full Text] [Related]
10. Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics. Buzzi RM; Owczarek CM; Akeret K; Tester A; Pereira N; Butcher R; Brügger-Verdon V; Hardy MP; Illi M; Wassmer A; Vallelian F; Humar R; Hugelshofer M; Buehler PW; Gentinetta T; Schaer DJ Mol Pharm; 2021 Aug; 18(8):3158-3170. PubMed ID: 34292741 [TBL] [Abstract][Full Text] [Related]
11. Haptoglobin Is a Divergent MASP Family Member That Neofunctionalized To Recycle Hemoglobin via CD163 in Mammals. Redmond AK; Ohta Y; Criscitiello MF; Macqueen DJ; Flajnik MF; Dooley H J Immunol; 2018 Oct; 201(8):2483-2491. PubMed ID: 30194112 [TBL] [Abstract][Full Text] [Related]
12. Regulation of CD163 associated casein kinase II activity is haptoglobin genotype dependent. Strauss M; Levy AP Mol Cell Biochem; 2008 Oct; 317(1-2):131-5. PubMed ID: 18563533 [TBL] [Abstract][Full Text] [Related]
13. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Buehler PW; Abraham B; Vallelian F; Linnemayr C; Pereira CP; Cipollo JF; Jia Y; Mikolajczyk M; Boretti FS; Schoedon G; Alayash AI; Schaer DJ Blood; 2009 Mar; 113(11):2578-86. PubMed ID: 19131549 [TBL] [Abstract][Full Text] [Related]
14. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes? Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971 [TBL] [Abstract][Full Text] [Related]
15. Haptoglobin: From hemoglobin scavenging to human health. di Masi A; De Simone G; Ciaccio C; D'Orso S; Coletta M; Ascenzi P Mol Aspects Med; 2020 Jun; 73():100851. PubMed ID: 32660714 [TBL] [Abstract][Full Text] [Related]
16. Haptoglobin polymorphism and body iron stores. Delanghe JR; Langlois MR Clin Chem Lab Med; 2002 Mar; 40(3):212-6. PubMed ID: 12005209 [TBL] [Abstract][Full Text] [Related]
17. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Graversen JH; Madsen M; Moestrup SK Int J Biochem Cell Biol; 2002 Apr; 34(4):309-14. PubMed ID: 11854028 [TBL] [Abstract][Full Text] [Related]
18. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Schaer DJ; Schaer CA; Buehler PW; Boykins RA; Schoedon G; Alayash AI; Schaffner A Blood; 2006 Jan; 107(1):373-80. PubMed ID: 16189277 [TBL] [Abstract][Full Text] [Related]
19. Haptoglobin polymorphism: a key factor in the proatherogenic role of B cells? Delanghe JR; Langlois MR; De Buyzere ML Atherosclerosis; 2011 Jul; 217(1):80-2. PubMed ID: 21507405 [TBL] [Abstract][Full Text] [Related]
20. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding. Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]